Cardiorenal Syndrome: A Comprehensive Pharmacological Perspective

Authors

  • Amany Mokbel Zayed El desouky , Mohammed Mohammed Shehata , Ibrahim Ali Awwad , Rasha Mohammed Sabry

Keywords:

Cardiorenal Syndrome, Pathogenesis

Abstract

Cardiorenal syndrome (CRS) represents a complex pathophysiological interplay between the heart and kidneys, where
dysfunction in one organ precipitates a cascade of adverse effects in the other. This bidirectional relationship poses
significant therapeutic challenges, necessitating a multidisciplinary approach to optimize patient outcomes. CRS is
classified into five distinct subtypes, each with unique mechanisms and clinical implications, including acute and chronic
heart failure-related renal dysfunction, primary renal dysfunction affecting the heart, and systemic conditions impacting
both organs simultaneously

References

Ronco C, Haapio M, House AA, Anker SD, Bellomo R. Cardiorenal syndrome. Journal of the American College of Cardiology. 2008;52(19):1527-1539. 2. McCullough PA, Kellum JA, Haase M, Müller C, Damman K, Murray PT, Cruz D, House AA, Schmidt-Ott KM,

Vescovo G, Bagshaw SM, Hoste EA, Briguori C, McAlister FA, Haapio M, Mankad S, Zanco P, Katz N, Ronco C. Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). American Journal of Nephrology. 2013;38(1):43-50.

Downloads

Published

2024-09-23

How to Cite

Amany Mokbel Zayed El desouky , Mohammed Mohammed Shehata , Ibrahim Ali Awwad , Rasha Mohammed Sabry. (2024). Cardiorenal Syndrome: A Comprehensive Pharmacological Perspective. Journal of Computational Analysis and Applications (JoCAAA), 33(06), 1400–1407. Retrieved from https://eudoxuspress.com/index.php/pub/article/view/1956

Issue

Vol. 33 No. 06 (2024): JOCAAA

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.